Triclabendazole
Triclabendazole is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
Triclabendazole is not currently FDA approved for use in the United States.
- Available through the CDC under an investigational drug protocol
- Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
Triclabendazole is not currently FDA approved for use in the United States.
- Available through the CDC under an investigational drug protocol
- Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved